Requisite Role of the Cholinergic Alpha7 Nicotinic Acetylcholine Receptor Pathway in Suppressing Gram-negative Sepsis-induced Acute Lung Inflammatory Injury
Overview
Authors
Affiliations
Although activation of the alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) modulates the response to sepsis, the role of this pathway in the development of sepsis-induced acute lung injury (ALI) is not known. In this study, we addressed the contribution of alpha7 nAChR in mediating endotoxin- and live Escherichia coli-induced ALI in mice. Because we found that alpha7 nAChR(+) alveolar macrophages and neutrophils were present in bronchoalveolar lavage and injured lungs of mice, we tested whether acetylcholine released by lung vagal innervation stimulated these effector cells and thereby down-regulated proinflammatory chemokine/cytokine generation. Administration of alpha7 nAChR agonists reduced bronchoalveolar lavage MIP-2 production and transalveolar neutrophil migration and reduced mortality in E. coli pneumonia mice, whereas vagal denervation increased MIP-2 production and airway neutrophil accumulation and increased mortality. In addition, alpha7 nAChR(-/-) mice developed severe lung injury and had higher mortality compared with alpha7 nAChR(+/+) mice. The immunomodulatory cholinergic alpha7 nAChR pathway of alveolar macrophages and neutrophils blocked LPS- and E. coli-induced ALI by reducing chemokine production and transalveolar neutrophil migration, suggesting that activation of alpha7 nAChR may be a promising strategy for treatment of sepsis-induced ALI.
Inhibition of acute lung inflammation by a neuroimmune circuit induced by vagal nerve stimulation.
Murray K, Cremin M, Tay E, Sanchez K, Schreiber S, Brust-Mascher I bioRxiv. 2025; .
PMID: 40027796 PMC: 11870408. DOI: 10.1101/2025.02.12.637880.
Wang N, Ma Q, Zhang J, Wang J, Li X, Liang Y Front Pharmacol. 2024; 15:1415951.
PMID: 39364045 PMC: 11446850. DOI: 10.3389/fphar.2024.1415951.
Neural Circuitries between the Brain and Peripheral Solid Tumors.
Chen X, Geng Y, Wei G, He D, Lv J, Wen W Cancer Res. 2024; 84(21):3509-3521.
PMID: 39226520 PMC: 11532784. DOI: 10.1158/0008-5472.CAN-24-1779.
Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury.
Wu D, Liao X, Gao J, Gao Y, Li Q, Gao W Clin Transl Med. 2024; 14(8):e1808.
PMID: 39129233 PMC: 11317502. DOI: 10.1002/ctm2.1808.
Neuroimmune recognition and regulation in the respiratory system.
Chen J, Lai X, Song Y, Su X Eur Respir Rev. 2024; 33(172).
PMID: 38925790 PMC: 11216688. DOI: 10.1183/16000617.0008-2024.